
Corporate
Ultragenyx Crashes 44% After Setrusumab Fails Two Phase 3 Trials
Dec 29, 2025
You're signed outSign in or to get full access.
Browse executives, board members, and key leadership.

President and Chief Executive Officer
Chief Technical Operations Officer and Gene Therapy Operations and Executive Vice President
Chief Medical Officer and Executive Vice President
Chief Commercial Officer and Executive Vice President
Chief Financial Officer, Corporate Strategy and Executive Vice President
Chief Quality Officer and Executive Vice President of Translational Sciences
Chief Legal Officer & Corporate Affairs and Executive Vice President
Chief Business Officer and Executive Vice President